Firm tried to block report on failure of AIDS vaccineBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7270.1173 (Published 11 November 2000) Cite this as: BMJ 2000;321:1173
- Scott Gottlieb
- New York
A Californian biotechnology company tried to block publication of a major AIDS study that found that the experimental treatment the company was developing failed to improve the health of patients, the scientists conducting the research said.
The Immune Response company of Carlsbad, California, opposed publication of the study because it did not include a subanalysis it believed showed that the treatment boosted the immune systems of some patients.
But despite the objections of the company, the researchers, led by James Kahn of the University of California at San Francisco, submitted their results to JAMA, which published them.
The study, of 2527 patients at 77 hospitals, tested a therapeutic vaccine, marketed under the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial